simalikalactone d has been researched along with glaucarubolone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pierré, A; Polonsky, J; Robert-Géro, M; Tempête, C | 1 |
| Grieco, P; Grünert, HP; Maxeiner, HG; Morré, DJ; Sawitzky, D; Zeichhardt, H | 1 |
2 other study(ies) available for simalikalactone d and glaucarubolone
| Article | Year |
|---|---|
Structural requirements of quassinoids for the inhibition of cell transformation.
Topics: Avian Sarcoma Viruses; Cell Transformation, Viral; DNA; DNA Replication; Dose-Response Relationship, Drug; Glaucarubin; Lactones; Leucine; Phenanthrenes; Protein Biosynthesis; Quassins; RNA; Structure-Activity Relationship | 1980 |
Effect of the quassinoids glaucarubolone and simalikalactone D on growth of cells permanently infected with feline and human immunodeficiency viruses and on viral infections.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cats; Cell Division; Cell Transformation, Viral; Glaucarubin; HIV-1; Humans; Immunodeficiency Virus, Feline; Quassins | 1998 |